2017 DeLynn Lecture
Precision public health: High value strategies to decrease the burden of cancer on the health of communities
DEBORAH SCHRAG, MD, MPH
Deborah Schrag’s research focuses on evaluating and improving the quality and effectiveness of cancer care delivery and, on the clinical side, she focuses on the care of patients with tumors of the lower gastrointestinal tract, particularly colorectal cancer. She is co-leader of the Dana-Farber Harvard Program in Cancer Care Delivery Research. Her current work focuses on building capacity for “phenomics” to complement and integrate with the surge of information in “genomics” in order to decrease the population burden of malignant disease.
Dr. Schrag consults for the Center for Medicare and Medicaid Services and state health departments, and has testified before Congressional panels on improving cancer care quality and efficiency. Dr. Schrag serves as a member of the NCI standing study section on Health Services Organization and Delivery as well as a member of the National Cancer Policy Forum. She is an Associate Editor of the Journal of the American Medical Association.
Dr. Schrag earned her medical degree from Columbia University College of Physicians and Surgeons and her Master of Public Health from the Harvard School of Public Health. She completed her residency in internal medicine at Brigham and Women’s Hospital and a fellowship in medical oncology at Dana-Farber. From 1998 to 2007, she practiced medical oncology in the Division of Gastrointestinal Oncology at Memorial Sloan-Kettering Cancer Center, where she was an Associate Professor of Public Health and Medicine.
The WVU Cancer Institute is the umbrella structure that encompasses all the cancer-related efforts of West Virginia University, including our formal partners at regional cancer facilities, research labs in Morgantown, and statewide prevention and control programs.